We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$22.6B
AUM Growth
+$4.98B
Cap. Flow
+$4.53B
Cap. Flow %
20.05%
Top 10 Hldgs %
40.91%
Holding
2,774
New
620
Increased
589
Reduced
714
Closed
789

Sector Composition

Rank Sector Weight
1 Technology 11.68%
2 Industrials 8.46%
3 Financials 6.56%
4 Consumer Discretionary 5.98%
5 Healthcare 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRT icon
801
Independence Realty Trust
IRT
$4B
$2.42M 0.01%
138,632
-1,019,284
-88% -$16.9M
CHRW icon
802
PUT
C.H. Robinson
CHRW
$17.1B
$2.41M 0.01%
+15,000
New +$2.22M
LTC
803
LTC Properties
LTC
$2.13B
$2.4M 0.01%
69,862
+32,997
+90% +$1.16M
NOMD icon
804
Nomad Foods
NOMD
$1.65B
$2.4M 0.01%
191,858
+150,864
+368% +$1.84M
PHG icon
805
Philips
PHG
$25.7B
$2.39M 0.01%
91,563
+82,512
+912% +$2.2M
CBC
806
Central Bancompany Inc
CBC
$7.99B
$2.39M 0.01%
+99,051
New +$2.33M
BIDU icon
807
Baidu
BIDU
$37.1B
$2.39M 0.01%
18,280
+16,229
+791% +$2.01M
CADE
808
DELISTED
Cadence Bank
CADE
$2.39M 0.01%
55,675
+42,193
+313% +$1.67M
PEG icon
809
Public Service Enterprise Group
PEG
$37.4B
$2.38M 0.01%
29,687
-24,901
-46% -$2.03M
DRDB
810
Roman DBDR Acquisition Corp II
DRDB
$326M
$2.38M 0.01%
228,293
-1,307
-0.6% -$13.6K
VKTX icon
811
Viking Therapeutics
VKTX
$3.88B
$2.38M 0.01%
67,647
-176,812
-72% -$6.26M
AVPT icon
812
AvePoint
AVPT
$2.71B
$2.37M 0.01%
170,661
+156,083
+1,071% +$2.16M
DRUG
813
Bright Minds Biosciences
DRUG
$793M
$2.36M 0.01%
30,211
-36,395
-55% -$2.43M
RRR icon
814
Red Rock Resorts
RRR
$3.68B
$2.35M 0.01%
37,940
-69,568
-65% -$4.07M
INGM
815
Ingram Micro Holding
INGM
$6.59B
$2.33M 0.01%
109,338
+24,133
+28% +$523K
MORN icon
816
Morningstar
MORN
$7.37B
$2.33M 0.01%
10,712
-13,533
-56% -$2.93M
RCUS icon
817
Arcus Biosciences
RCUS
$3.61B
$2.32M 0.01%
97,283
+48,389
+99% +$987K
BCAR
818
D. Boral ARC Acquisition I Corp
BCAR
$196M
$2.31M 0.01%
230,000
-27,631
-11% -$277K
GNL icon
819
Global Net Lease
GNL
$1.91B
$2.3M 0.01%
267,822
+25,114
+10% +$201K
INSP icon
820
Inspire Medical Systems
INSP
$1.7B
$2.3M 0.01%
24,947
+19,794
+384% +$1.89M
RCL icon
821
Royal Caribbean
RCL
$85.7B
$2.3M 0.01%
+8,235
New +$2.33M
AI icon
822
C3.ai
AI
$1.53B
$2.29M 0.01%
169,880
-7,633
-4% -$122K
AES icon
823
AES
AES
$10.5B
$2.29M 0.01%
159,355
+41,304
+35% +$582K
OSCR icon
824
Oscar Health
OSCR
$8B
$2.28M 0.01%
+158,833
New +$2.75M
RXST icon
825
RxSight
RXST
$253M
$2.28M 0.01%
218,675
-338,926
-61% -$3.4M

Similar funds

Schonfeld Strategic Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Schonfeld Strategic Advisors held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Schonfeld Strategic Advisors deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
  • Schonfeld Strategic Advisors added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
  • Schonfeld Strategic Advisors's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
  • Schonfeld Strategic Advisors fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
  • Schonfeld Strategic Advisors opened 620 new positions and closed 789 in Q4 2025.
  • Schonfeld Strategic Advisors's portfolio value rose 28% quarter-over-quarter to $22.6B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.